← Back to catalogue

MLH1 IHC pharmDx (Dako Omnis)

FDA UDI

Class III (US FDA UDI)

by Agilent Technologies Inc.

Identity

Trade Name
MLH1 IHC pharmDx (Dako Omnis) FDA UDI
Generic Name
MLH1 antigen IVD, antibody FDA UDI
Device Name
MLH1 IHC pharmDx (Dako Omnis) FDA UDI
Model / Reference
GE079 FDA UDI
Description
MLH1 IHC pharmDx (Dako Omnis) FDA UDI

Identifiers

Primary DI / UDI-DI
05700575005213 FDA UDI
PMA Number
P250004 FDA UDI
FDA Product Code
QNH FDA UDI
GMDN Term
MLH1 antigen IVD, antibody FDA UDI

Classification

Device Class
Class III FDA UDI
Regulation Number
864.1860 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Dimensions & Sizes

Size
Total Volume — 12 Milliliter FDA UDI

Category: MLH1 antigen IVD, antibody

MLH1 IHC pharmDx (Dako Omnis) by Agilent Technologies Inc. — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as MLH1 antigen IVD, antibody.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI afaf760f-60e9-4bdf-b9b4-03e38dab62be 37 fields · synced May 31, 2026